Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund (GHIT Fund) is an international public-private partnership fund between five Japanese pharmaceutical companies, two government ministries and the Bill & Melinda Gates Foundation. Launched in April 2013 with a five-year commitment of more than US$100 million, the organization taps Japanese research and development (R&D) innovation to fight neglected diseases. It is the first fund to involve a consortium of pharmaceutical companies, government and civil society working together to support R&D for neglected diseases. The combination of Japan’s government and its pharmaceutical industry—the third largest in the world—brings a powerful engine of knowledge and innovation to the development of medications for the developing world. The GHIT Fund invests via grants in the development of new drugs, vaccines, or diagnostics for infectious diseases that are prevalent in the developing world, including HIV/AIDS, Tuberculosis, Malaria, and other NTDs.